In vitro effects of antihypertensive drugs on thromboxane agonist (U46619)-induced vasocontriction in human internal mammary artery

British Journal of Anaesthesia

Volumn 93, Issue 2, 2004, Pages 257-262

  Tanaka, K A ^a   Szlam, F ^a   Katori, N ^a   Tsuda, A ^a   Levy, Jerrold H ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Agonists, thromboxane; Arterial pressure, antihypertensives; Arteries, internal mammary artery; Complications, vasoconstriction

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ADENOSINE; ANTIHYPERTENSIVE AGENT; ENALAPRILAT; FENOLDOPAM; GLYCERYL TRINITRATE; HYDRALAZINE; LABETALOL; NICARDIPINE; NICORANDIL; NITROPRUSSIDE SODIUM; NORADRENALIN;

ARTICLE; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; FEMALE; HUMAN; HUMAN TISSUE; INTERNAL MAMMARY ARTERY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; VASOCONSTRICTION; VASODILATATION;

EID: 4344618096     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/aeh189     Document Type: Article

References (22)

1. Belhassen L, Pelle G, Dubois-Rande JL, Adnot S. Improved endothelial function by the thromboxane A2 receptor antagonist S 18886 in patients with coronary artery disease treated with aspirin. J Am Coll Cardiol 2003; 41: 1198-204
2. Hayakawa H, Raij L. Relationship between hypercholesterolaemia, endothelial dysfunction and hypertension. J Hypertens 1999; 17: 611-9
3. Ungvari Z, Koller A. Endothelin and prostaglandin H(2)/thromboxane A(2) enhance myogenic constriction in hypertension by increasing Ca(2+) sensitivity of arteriolar smooth muscle. Hypertension 2000; 36: 856-61
4. Luscher TF, Noll G. The pathogenesis of cardiovascular disease: role of the endothelium as a target and mediator. Atherosclerosis 1995; 118 (Suppl.): S81-90
5. Kritz H, Schmid P, Keiler A, O'Grady J, Sinzinger H. Isradipine increases vascular prostaglandin 12-formation while the thromboxane B2-synthesis is diminished. Thromb Res 1995; 80: 483-9
6. Munzel T, Sayegh H, Freeman BA, Tarpey MM, Harrison DG. Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance. J Clin Invest 1995; 95: 187-94
7. Watkins WD, Peterson MB, Kong DL, et al. Thromboxane and prostacyclin changes during cardiopulmonary bypass with and without pulsatile flow. J Thoroc Cardiovasc Surg 1982; 84: 250-6
8. Eikelboom JW, Hirsh J, Weitz JI, et al. Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. Circulation 2002; 105: 1650-5
9. Huraux C, Makita T, Montes F, Szlam F, Levy JH. A comparative evaluation of the effects of multiple vasodilators on human internal mammary artery. Anesthesiology 1998; 88: 1654-9
10. Hamu Y, Kanmura Y, Tsuneyoshi I, Yoshimura N. The effects of vasopressin on endotoxin-induced attenuation of contractile responses in human gastroepiploic arteries in vitro. Anesth Analg 1999; 88: 542-8
11. Sato N, Tanaka KA, Szlam F, Tsuda A, Arias ME, Levy JH. The vasodilatory effects of hydralazine, nicardipine, and fenoldopam in the human umbilical artery. Anesth Analg 2003; 96: 539-44
12. Huraux C, Makita T, Szlam F, Nordlander M, Levy JH. The vasodilator effects of clevidipine on human internal mammary artery. Anesth Analg 1997; 85: 1000-4
13. Hamilton CA, O'Dowd G, McIntosh L, et al. Vasorelaxant properties of isolated human radial arteries: comparison with internal mammary arteries. Atherosclerosis 2002; 160: 345-53
14. The IONA study group. Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial. Lancet 2002; 359: 1269-75
15. Sadaba JR, Mathew K, Munsch CM, Beech DJ. Vasorelaxant properties of nicorandil on human artery. Eur J Cardiothorac Surg 2000; 17: 319-24
16. He GW, Acuff TE, Ryan WH, et al. Inhibitory effects of calcium antagonists on alpha-adrenoceptor-mediated contraction in the human internal mammary artery. Br J Clin Pharmacol 1994; 37: 173-9
17. Hughes AD, Sever PS. Action of fenoldopam, a selective dopamine (DAI) receptor agonist, on isolated human arteries. Blood Vessels 1989; 26: 119-27
18. Gretler DD, Elliott WJ, Moscucci M, Childers RW, Murphy MB. Electrocardiographic changes during acute treatment of hypertensive emergencies with sodium nitroprusside or fenoldopam. Arch Int Med 1992; 152: 2445-8
19. Jett GK, Guyton RA, Hatcher CR,jr, Abel PW. Inhibition of human internal mammary artery contractions. An in vitro study of vasodilators. J Thorac Cardiovasc Surg 1992; 104: 977-82
20. Luscher TF, Diederich D, Siebenmann R, et al. Difference between endothelium-dependent relaxation in arterial and in venous coronary bypass grafts. N Eng J Med 1988; 319: 462-7
21. Vila JM, Martinez-Leon JB, Medina P, et al. U-46619-induced potentiation of noradrenergic constriction in the human saphenous vein: antagonism by thromboxane receptor blockade. Cardiovasc Res 2001; 52: 462-7
22. Mombouli JV, Illiano S, Nagao T, Scott-Burden T, Vanhoutte PM. Potentiation of endothelium-dependent relaxations to bradykinin by angiotensin I converting enzyme inhibitors in canine coronary artery involves both endothelium-derived relaxing and hyperpolarizing factors. Circ Res 1992; 71: 137-4